Authors: ZORN U DUENSING S LANGKOPF F ANASTASSIOU G KIRCHNER H HADAM M KNUVERHOPF J ATZPODIEN J

Citation: U. Zorn et al., ACTIVE SPECIFIC IMMUNOTHERAPY OF RENAL-CELL CARCINOMA - CELLULAR AND HUMORAL IMMUNE-RESPONSES, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(3), 1997, pp. 157-165

Authors: KNUVERHOPF J MOHR H

Citation: J. Knuverhopf et H. Mohr, DIFFERENCES BETWEEN NATURAL AND RECOMBINANT INTERLEUKIN-2 REVEALED BYGEL-ELECTROPHORESIS AND CAPILLARY ELECTROPHORESIS, Journal of chromatography, 717(1-2), 1995, pp. 71-74

Authors: KNUVERHOPF J LAMBRECHT B MOHR H

Citation: J. Knuverhopf et al., AN ELECTROPHORETIC STUDY AND AMINO-ACID-ANALYSIS OF BLOOD PROTEINS BEFORE AND AFTER PHOTODYNAMIC TREATMENT OF HUMAN PLASMA, Infusionstherapie und Transfusionsmedizin, 22, 1995, pp. 5-7

Authors: BACHMANN B KNUVERHOPF J LAMBRECHT B MOHR H

Citation: B. Bachmann et al., TARGET STRUCTURES FOR HIV-1 INACTIVATION BY METHYLENE-BLUE AND LIGHT, Journal of medical virology, 47(2), 1995, pp. 172-178

Authors: ATZPODIEN J HANNINEN EL KIRCHNER H KNUVERHOPF J POLIWODA H

Citation: J. Atzpodien et al., HUMAN-ANTIBODIES TO RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH HYPERNEPHROMA, Journal of interferon research, 14(4), 1994, pp. 177-178

Authors: HANNINEN EL KNUVERHOPF J ATZPODIEN J

Citation: El. Hanninen et al., IMMUNOGENICITY OF RECOMBINANT HUMAN INTERLEUKIN-2 - BIOLOGICAL FEATURES AND CLINICAL RELEVANCE, Biotherapy, 6(4), 1993, pp. 251-261